These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3060706)

  • 1. A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem.
    Cadet JL
    Med Hypotheses; 1988 Sep; 27(1):59-63. PubMed ID: 3060706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen radicals and neuropsychiatric illness. Some speculations.
    Lohr JB
    Arch Gen Psychiatry; 1991 Dec; 48(12):1097-106. PubMed ID: 1845228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.
    Rossor MN
    Br Med J (Clin Res Ed); 1981 Dec; 283(6306):1588-90. PubMed ID: 6118194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias.
    Trojanowski JQ; Lee VM
    Ann N Y Acad Sci; 1994 Dec; 747():92-109. PubMed ID: 7847694
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurodegenerative disorders and aging. Alzheimer's disease and Parkinson's disease--common ground.
    Hamill RW; Caine E; Eskin T; Lapham L; Shoulson I; McNeill TH
    Ann N Y Acad Sci; 1988; 515():411-20. PubMed ID: 3284427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nervous system and free radicals].
    Hirai S
    No To Shinkei; 1992 Jul; 44(7):595-604. PubMed ID: 1329887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemistry of the physiopathologic and clinical aspects of free radicals in cerebral degenerative diseases such as Alzheimer's and Parkinson diseases].
    Hirai S
    Nihon Rinsho; 1988 Oct; 46(10):2184-9. PubMed ID: 3266509
    [No Abstract]   [Full Text] [Related]  

  • 8. A cortical vs. subcortical distinction of dementia contrasts with the unifying pathoetiology of Alzheimer's and Parkinson's disease.
    Iacono RP; Sandyk R; Consroe PF; Bamford CR
    Int J Neurosci; 1987 Feb; 32(3-4):983-5. PubMed ID: 3596941
    [No Abstract]   [Full Text] [Related]  

  • 9. [Do the glutamate excitotoxicity theory and potential free radicals implication in schizophrenia aetiopathogenesis provide a new enlightenment to links between: genome, environment and biology in the determinism of that disorder?].
    Nguimfack Mbodie PC
    Encephale; 2002; 28(2):147-53. PubMed ID: 11972141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
    Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia and Parkinson's disease--pathological and neurochemical considerations.
    Quinn NP; Rossor MN; Marsden CD
    Br Med Bull; 1986 Jan; 42(1):86-90. PubMed ID: 3006860
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies.
    Nemeroff CB; Bissette G
    Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease as a disorder of isodendritic core.
    Benton JS; Bowen DM; Allen SJ; Haan EA; Davison AN; Neary D; Murphy RP; Snowden JS
    Lancet; 1982 Feb; 1(8269):456. PubMed ID: 6121126
    [No Abstract]   [Full Text] [Related]  

  • 15. The neuropsychiatry of brain iron.
    Sachdev P
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):18-29. PubMed ID: 8094018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amyloid deposits in Alzheimer's disease: their nature and pathogenesis.
    Glenner GG; Wong CW; Quaranta V; Eanes ED
    Appl Pathol; 1984; 2(6):357-69. PubMed ID: 6242724
    [No Abstract]   [Full Text] [Related]  

  • 17. Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia.
    Abramsky O; Litvin Y
    Perspect Biol Med; 1978; 22(1):104-14. PubMed ID: 733451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Alzheimer's disease and other neurodegenerative disorders caused by impaired signalling of insulin and other hormones?
    Hölscher C; De Felice FG; Greig NH; Ferreira ST
    Neuropharmacology; 2018 Jul; 136(Pt B):159. PubMed ID: 29782874
    [No Abstract]   [Full Text] [Related]  

  • 19. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fat-soluble vitamin therapy in senile dementia and Parkinson's disease].
    Nakashima K; Takahashi K
    Nihon Rinsho; 1993 Apr; 51(4):1017-22. PubMed ID: 8483257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.